A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in United Therapeutics Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 960 shares of UTHR stock, worth $363,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
960
Holding current value
$363,004
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$311.04 - $363.55 $298,598 - $349,008
960 New
960 $344 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Holding Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Holding Ag with notifications on news.